Innovation in Action
Clinical Trials
In 2009, Baxter advanced 13 Phase III clinical trials and numerous early-stage programs that have the potential to profoundly impact the treatment and delivery of care for chronic diseases like Alzheimer's disease, hemophilia, end-stage renal disease, immune deficiencies, as well as public health threats like pandemic and seasonal influenza.
- National Institutes of Health | Clinical Trials (http://www.clinicaltrials.gov/)
